期刊文献+

The value of 18-FDG-PET for diagnosing and evaluating lymph node metastasis in primary breast cancer

The value of 18-FDG-PET for diagnosing and evaluating lymph node metastasis in primary breast cancer
下载PDF
导出
摘要 Objective: To analyze the result of 18F-2-deoxy-2-fluoro-D-glucose-positron emission tomography (FDG-PET) in suspicious primary breast cancer patients and to evaluate its value for the surgery therapy. Methods: Total 36 patients suspected of breast neoplasm were enrolled into the research. The result was compared with the pathology result. The rate of missed diagnosis, the rate of mi.sdiagnosis. the sensitivity and specificity were calculated and analyzed. Results:Compared with the pathology results, the misdiagnosis rate. the rate of missed diagnosis. the sensitivity and specificity of FDG-PET for breast cancer were 0% , 36. 36%. 63. 63% and 100%, respectively. To those who had a neoplasm no more than 2 cm in diameter, the rate of missed diagnosis was as high as 41. 67%. To 33 breast cancer patients, the misdiagnosis rate, the rate of missed diagnosis, the sensitivity and specificity for lymph node metastasis were 18. 75%, 41. 18%, 58. 82% and 81. 25%, respectively. Conclusion:FDG-PET has a perfect specificity and a considerable sensitivity to the primary breast neoplasm and similar to the lymph node metastasis diagnosis. It is an ideal choice for those patients with suspected breast cancer but reluctantly to receive a vulnerarious examination. Objective: To analyze the result of 18F-2-deoxy-2-fluoro-D-glucose-positron emission tomography (FDG-PET) in suspicious primary breast cancer patients and to evaluate its value for the surgery therapy. Methods: Total 36 patients suspected of breast neoplasm were enrolled into the research. The result was compared with the pathology result. The rate of missed diagnosis, the rate of misdiagnosis, the sensitivity and specificity were calculated and analyzed. Results :Compared with the pathology results, the misdiagnosis rate, the rate of missed diagnosis, the sensitivity and specificity of FDG-PET for breast cancer were 0%, 36.36%, 63.63% and 100%, respectively. To those who had a neoplasm no more than 2 cm in diameter, the rate of missed diagnosis was as high as 41.67%. To 33 breast cancer patients, the misdiagnosis rate, the rate of missed diagnosis, the sensitivity and specificity for lymph node metastasis were 18.75%, 41.18%, 58.82% and 81.25%, respectively. Conclusion:FDG-PET has a perfect specificity and a considerable sensitivity to the primary breast neoplasm and similar to the lymph node metastasis diagnosis. It is an ideal choice for those patients with suspected breast cancer but reluctantly to receive a vulnerarious examination.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2007年第1期49-53,共5页 中国人民解放军军医大学学报(英文版)
关键词 原发性乳腺癌 淋巴结转移 诊断 评价 PET breast cancer diagnosis PET
  • 相关文献

参考文献10

  • 1[1]Santiago JF,Gonen M,Yeung H et al.A retrospective analysis of the impact of (18)F-FDG PET scans on clinical management of 133 breast cancer patients[J].J Nucl Med Mol Imaging,2006;50:61.
  • 2[2]Fueger BJ,Weber WA,Quon A et al.Performance of 2-deoxy2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients[J].Mol Imaging Biol,2005;7:369.
  • 3[3]Beresford M,Padhani AR,Goh V et al.Imaging breast cancer response during neoadjuvant systemic therapy[J].Expert Rev Anticancer Ther,2005;5:893.
  • 4[4]Kumar R,Loving VA,Chauhan A et al.Potential of dual-timepoint imaging to improve breast cancer diagnosis with (18)FFDG PET[J].J Nucl Med,2005;46:1819.
  • 5[5]Kumar R,Nadig MR,Chauhan A.Positron emission tomography:clinical applications in oncology.Part 1[J].Expert Rev Anticancer Ther,2005;5:1079.
  • 6[6]Tse NY,Hoh CK,Hawkins RA et al.The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease[J].Ann Surg,1992;216:27.
  • 7[7]Kumar R,Zhuang H,Schnall M et al.FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer[J].Nucl Med Commun,2006;27:231.
  • 8[8]Lamy PJ,Comte F,Eberle MC.Combined role of tumor markers and 18fluoro deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients[J].Bull Cancer,2005;92:858.
  • 9[9]Utech CI,Young CS,Winter PF.Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry[J].Eur J Nucl Med,1996;23(12):1588.
  • 10[10]Kenny LM,Vigushin DM,Al-Nahhas A et al.Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by[18F]fluorothymidine-positron emission tomography imaging:evaluation of analytical methods[J].Cancer Res,2005;65:10104.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部